Bowel cancer prediction test for IBD patients 90% accurate
A new method for detecting bowel cancer is more than 90% accurate at predicting which higher-risk people will develop the disease, according to research.
Calcium Intake and Colorectal Cancer Risk: What You Need to Know
Calcium Intake and Colorectal Cancer Risk: What You Need to Know
Bowel cancer breakthrough as bacteria that causes grim infection could be key to new treatments
cientists are suggesting that Salmonella bacteria could be harnessed to combat cancer. UK researchers are investigating the potential for these bacteria to inhibit tumour cell proliferation in bowel cancer cases.
AdventHealth brings comprehensive cancer care to Palm Coast
The Freytag Cancer Center at AdventHealth Palm Coast.
New treatment option successfully tested
Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face.
Pfizer Inc (PFE) Showcases Groundbreaking Genitourinary Cancer Research at ASCO GU Symposium
Pfizer Inc (PFE, Financial) is set to present significant findings from its genitourinary (GU) cancer portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium from February 13-15 in San Francisco.
Leap scraps late-stage plans for gastric cancer therapy after mid-stage setback
Leap Therapeutics (NASDAQ:LPTX) lost 63% in the premarket on Tuesday after the antibody-based drug developer announced that it would not advance its lead candidate, sirexatamab, in Phase 3 studies for gastric cancer following disappointing data from a mid-stage trial.
5 Easy Breakfast Ideas That ‘Lower Your Cancer Risk,’ According To A Registered Dietitian
Breakfast is often considered the most important meal of the day, and making smart choices can do more than just fuel your morning—it can also impact your long-term health.
Biotech CEO predicts ‘revolutionary’ steps toward curing cancer on horizon thanks to AI
SELLAS Life Sciences CEO Angelos Stergiou says his company is already on the cusp of a finalized leukemia vaccine, but another game-changer – personalized cancer vaccines – could be on the horizon, thanks to artificial intelligence.
Pfizer succeeds in late-stage trial for colorectal cancer therapy
Pfizer (NYSE:PFE) announced Saturday that its colorectal cancer therapy Braftovi, as part of a combination regimen, reduced tumor size (confirmed objective response rate) in a late-stage trial with a clinically meaningful and statistically significant effect.
Peptide-coated nanoparticles achieve 98% drug loading, improving cancer treatment
A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy, as demonstrated in leukemia models.
Bristol Myers colorectal cancer drug cuts relapse risk (BMY) | Seeking Alpha
Bristol Myers Squibb (BMY) says its cancer drugs Opdivo and Yervoy improved progression-free survival in a Phase 3 trial for certain colorectal cancer. Read more here.
